1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Hypertropic Cardiomyopathy Global Clinical Trials Review, H2, 2014

Hypertropic Cardiomyopathy Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Hypertropic Cardiomyopathy Global Clinical Trials Review, H2, 2014" provides data on the Hypertropic Cardiomyopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypertropic Cardiomyopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hypertropic Cardiomyopathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Hypertropic Cardiomyopathy Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables3
List of Figures 4
Introduction 5
Hypertropic Cardiomyopathy 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Hypertropic Cardiomyopathy to Cardiovascular Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Hypertropic Cardiomyopathy 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Hypertropic Cardiomyopathy Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Gilead Sciences, Inc. 26
Clinical Trial Overview of Gilead Sciences, Inc. 26
Novartis AG 27
Clinical Trial Overview of Novartis AG 27
Heart Metabolics Ltd. 28
Clinical Trial Overview of Heart Metabolics Ltd. 28
A. Menarini Industrie Farmaceutiche Riunite Srl 29
Clinical Trial Overview of A. Menarini Industrie Farmaceutiche Riunite Srl 29
Clinical Trial Overview of Top Institutes / Government 30
National Heart, Lung, and Blood Institute 30
Clinical Trial Overview of National Heart, Lung, and Blood Institute 30
Johns Hopkins University 31
Clinical Trial Overview of Johns Hopkins University 31
University of Miami 32
Clinical Trial Overview of University of Miami 32
Brigham and Women's Hospital 33
Clinical Trial Overview of Brigham and Women's Hospital 33
Stanford University 34
Clinical Trial Overview of Stanford University 34
University of Calgary 35
Clinical Trial Overview of University of Calgary 35
Johann Wolfgang Goethe University Hospitals 36
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals 36
Massachusetts General Hospital 37
Clinical Trial Overview of Massachusetts General Hospital 37
Duke University 38
Clinical Trial Overview of Duke University 38
Assistance Publique - Hopitaux de Paris 39
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 39
Five Key Clinical Profiles 40
Appendix 56
Abbreviations 56
Definitions 56
Research Methodology 57
Secondary Research 57
About GlobalData 58
Contact Us 58
Disclaimer 58
Source 58

List of Tables
Hypertropic Cardiomyopathy Therapeutics, Global, Clinical Trials by Region, 2014* 6
Hypertropic Cardiomyopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Hypertropic Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Hypertropic Cardiomyopathy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Hypertropic Cardiomyopathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Hypertropic Cardiomyopathy Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Hypertropic Cardiomyopathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Proportion of Hypertropic Cardiomyopathy to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 13
Hypertropic Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Hypertropic Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Hypertropic Cardiomyopathy Therapeutics, Global, Clinical Trials by Phase, 2014* 16
Hypertropic Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 17
Hypertropic Cardiomyopathy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Hypertropic Cardiomyopathy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Hypertropic Cardiomyopathy Therapeutics, Global, Terminated Clinical Trials, 2014* 20
Hypertropic Cardiomyopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Hypertropic Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 22
Hypertropic Cardiomyopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Hypertropic Cardiomyopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 24
Hypertropic Cardiomyopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014* 26
Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 27
Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Heart Metabolics Ltd., 2014* 28
Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by A. Menarini Industrie Farmaceutiche Riunite Srl, 2014* 29
Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 30
Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2014* 31
Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2014* 32
Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2014* 33
Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 34
Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Calgary, 2014* 35
Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2014* 36
Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 37
Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014* 38
Hypertropic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 39

List of Figures
Hypertropic Cardiomyopathy Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Hypertropic Cardiomyopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Hypertropic Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Hypertropic Cardiomyopathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Hypertropic Cardiomyopathy Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Hypertropic Cardiomyopathy to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 13
Hypertropic Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Hypertropic Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Hypertropic Cardiomyopathy Therapeutics, Global, Clinical Trials by Phase (%), 2014* 16
Hypertropic Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 17
Hypertropic Cardiomyopathy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Hypertropic Cardiomyopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Hypertropic Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 22
Hypertropic Cardiomyopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Hypertropic Cardiomyopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 24
Hypertropic Cardiomyopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
GlobalData Methodology 57

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.